ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Panel Objects To Act Change Requiring NCI Carcinogen Report

May 12, 1978

Illinois Congressman Calls For Full Bypass Budget Appropriation In cancer Prevention – $180 Million

February 22, 1991

Abbott PCR Test For HCV Load Sensitive to Within 12 IU/mL

May 27, 2011

NCI By Pass Budget For FY 1987 Is $1.57 Bil.

October 18, 1985

Upton Wraps Up Reorganization – DCCR Revamped, No Prevention Division

October 12, 1979

Greenwald Disagrees With WHT Report But Won’t Fight Decision; Will Ask For Limited Study, With Scope To Be Modified

January 15, 1988